🇬🇷 Greece Country × Condition
lung neoplasm malignant Clinical Trials in Greece
Active clinical trials for lung neoplasm malignant with research sites in Greece. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇬🇷 Greece
Active Trials in Greece (2)
NCT06079970
Recruiting
Confocal Laser Endomicroscopy VERification
Enrollment
208 pts
Country
🇬🇷 Greece
Amsterdam University Medical Center...
View Trial → NCT06788912 Phase 2
Recruiting
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Enrollment
60 pts
Country
🇬🇷 Greece
Merck Sharp & Dohme LLC
View Trial → Frequently Asked Questions
How many lung neoplasm malignant clinical trials are active in Greece?
There are currently 2 active clinical trials for lung neoplasm malignant with sites in Greece, of which 2 are actively recruiting patients.
How can I join a lung neoplasm malignant clinical trial in Greece?
To join a lung neoplasm malignant clinical trial in Greece, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Greece directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are lung neoplasm malignant trials in Greece?
Active lung neoplasm malignant trials in Greece span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology